Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) Return on Assets (2016 - 2025)

Historic Return on Assets for Traws Pharma (TRAW) over the last 13 years, with Q3 2025 value amounting to 1.12%.

  • Traws Pharma's Return on Assets rose 91200.0% to 1.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.12%, marking a year-over-year increase of 91200.0%. This contributed to the annual value of 5.98% for FY2024, which is 53200.0% down from last year.
  • According to the latest figures from Q3 2025, Traws Pharma's Return on Assets is 1.12%, which was up 91200.0% from 1.17% recorded in Q2 2025.
  • In the past 5 years, Traws Pharma's Return on Assets ranged from a high of 0.29% in Q4 2021 and a low of 10.25% during Q3 2024
  • In the last 5 years, Traws Pharma's Return on Assets had a median value of 0.7% in 2021 and averaged 2.21%.
  • Its Return on Assets has fluctuated over the past 5 years, first crashed by -95000bps in 2024, then soared by 91200bps in 2025.
  • Over the past 5 years, Traws Pharma's Return on Assets (Quarter) stood at 0.29% in 2021, then plummeted by -65bps to 0.47% in 2022, then crashed by -73bps to 0.82% in 2023, then tumbled by -929bps to 8.4% in 2024, then soared by 87bps to 1.12% in 2025.
  • Its Return on Assets was 1.12% in Q3 2025, compared to 1.17% in Q2 2025 and 6.47% in Q1 2025.